Biography
Peggy J. Berry, MBA, RAC, is the President & CEO at Synergy Consulting where she provides consulting services to companies in all aspects of drug development. She also provides group and one-on-one training in drug development, regulatory affairs and project management topics. Prior to founding Synergy Consulting in 2015, she was Vice President of Regulatory Affairs at Insmed where she was responsible for the development and implementation of global regulatory strategies and the management and oversight of the regulatory affairs department. Prior to Insmed, she was Vice President of Regulatory Affairs and Quality at Amarin. In addition, Ms. Berry consults for a number of companies in the regulatory and quality area, conducts a number of training courses, and is active in the Regulatory Affairs Professionals Society. She is the editor of the 2010 book “Choosing the Right Regulatory Career†(RAPS, MD) and author of the 2011 book “Communication & Negotiation†(RAPS, MD).
Research Interest
Regulatory Affairs
Biography
Prof David Naor is a professor of immunology in the Hebrew University, faculty of Medicine and was the head of Milton Winograd Chair of Cancer Studies. He received his Ph.D from the Hebrew University. He served as visiting professor in leading universities (e.g., UCLA, Harvard). He published 152 articles, including in leading journals like Nature, PNAS, J Clin Invest, J immunol, J Exp Med etc. He was invited to speak on CD44 at 8 plenary sessions of international conferences. He has been a member in editorial boards of several international scientific journals and he is an associate editor of Frontiers in Immunology. He is on the scientific board of International Congress on Autoimmunity. He received awards from Johnson & Johnson "In recognition of outstanding research towards the advances of science and technology in health care†and from the Hebrew University for his “outstanding achievements in research and teachingâ€.
Research Interest
Prof David Naor current research has been focused on the role of CD44 and other hyaluronan-binding molecules (e.g., RHAMM) in autoimmune and cancer diseases. This CD44 research yielded 34 articles, which were cited thousands of times.
Biography
Christina Leung completed two Bachelor degrees in England (the Management Sciences degree and the Pharmacy degree). Following the registration as a pharmacist in England, she worked in a number of teaching hospitals in London. After the completion of junior pharmacist training, Ms Leung spent 12 years as Women’s and Children’s Pharmacist, mainly specialising in Paediatric ICU, Paediatric Liver, Obstetrics & Gynaecology. She published a number of articles including two articles relating to drugs use in paediatric liver diseases. Ms Leung is also a registered pharmacist in HK and she is currently working as the Senior Pharmacist (Clincial Service) at HKU-SZH. She is currently the Honorary Lecturer at the University of Hong Kong.
Research Interest
Ms Leung has special intertess in clincial pharmacy system of different aspects and its impact in the quality of patient care. In addition, Ms Leung has great interests in medication safety, risk management, antimicrobial stewardship, quality management, training and education, and continuous professional development.